Reaching the one billion mark in Covid-19 vaccinations in just nine months is a ‘remarkable achievement’ for India, Krishna Ella, CMD, Bharat Biotech International Ltd, said.
“Bharat Biotech is proud to have contributed to this historic landmark,” Ella said in a statement issued on Thursday.
Also see: India administers 100 crore Covid vaccinations to achieve landmark milestone
“This is a unified effort of the Government, vaccine manufacturers, healthcare workers and all the vaccinated citizens of India, making it a true success story of Atmanirbharta, “ he added.
Covaxin, the first desi Covid-19 vaccine of Hyderabad-based Bharat Biotech, is administered in the public vaccination drive in the country along with Serum Institute’s Covishield and Russian vaccine Sputnik V.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.